Strategic Acquisition Evergen is transitioning under new ownership as RTI Surgical acquires Cook Biotech, signaling potential alignment on regenerative medicine offerings, distribution channels, and expanded collaboration opportunities for sales reps targeting existing RTI customers and Cook Biotech peripherals.

Regenerative Focus As a world leader in biologic tissue grafts using ECM technology, the company has a strong value proposition in soft-tissue repair, fistulas, hernias, and wound care, presenting cross-sell opportunities to hospitals and surgical centers focusing on regenerative solutions.

Medium-Sized Growth With 51-200 employees and estimated revenue in the mid single digits, there is measurable growth potential through targeted professional networks, clinical partnerships, and hospital procurement programs seeking scalable regenerative products.

Partnership History Past collaborations with Sanara MedTech and Aziyo Biologics indicate an openness to co-development and supply partnerships, suggesting channels for new co-branded products, joint ventures, or enhanced distribution deals.

Geographic Footprint Based in West Lafayette, Indiana with global product usage, opportunities exist to leverage regional sales teams, expand presence in U.S. markets emerging from the RTI integration, and pursue regional hospital systems and academic centers.